Anti-CD19 CAR-NK cells

Chimeric Antigen Receptor NK cell therapy targeting CD19 · Shahid Beheshti University of Medical Sciences

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Anti-CD19 CAR-NK cells, covering 2019-01-31 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus [Phase 1]